Agile Therapeutics, Inc., a forward-thinking women's healthcare company, focuses on the development and commercialization of prescription contraceptive products for women. The company has market cap of $97.09 million. The Company’s lead product candidate is Twirla, also known as AG200-15, a once-weekly contraceptive patch, which completed Phase III clinical trials. It currently has negative earnings. The firm is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide shorter lighter periods; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen.
Essent Group Ltd. (ESNT) formed wedge up with $47.07 target or 5.00% above today’s $44.83 share price. Essent Group Ltd. (ESNT) has $4.41 billion valuation. The stock increased 1.01% or $0.45 during the last trading session, reaching $44.83. About 929,446 shares traded or 7.34% up from the average. Essent Group Ltd. (NYSE:ESNT) has risen 81.69% since January 7, 2017 and is uptrending. It has outperformed by 64.99% the S&P500.
Investors sentiment increased to 1.75 in 2017 Q3. Its up 0.39, from 1.36 in 2017Q2. It increased, as 19 investors sold Essent Group Ltd. shares while 58 reduced holdings. 44 funds opened positions while 91 raised stakes. 83.02 million shares or 4.73% more from 79.27 million shares in 2017Q2 were reported. California State Teachers Retirement Systems reported 130,389 shares. Boston Prns holds 1.27 million shares. Deutsche Bancorporation Ag accumulated 266,428 shares. Dimensional Fund Lp holds 0.02% or 940,247 shares. Verition Fund Mngmt Ltd has invested 0.06% in Essent Group Ltd. (NYSE:ESNT). Teacher Retirement Systems Of Texas holds 0% or 6,904 shares in its portfolio. Arrowstreet Limited Partnership accumulated 495,537 shares. Convergence Invest Prtn Limited Liability Corporation holds 55,503 shares or 0.32% of its portfolio. Virginia Retirement Sys Et Al has invested 0.01% in Essent Group Ltd. (NYSE:ESNT). Robeco Institutional Asset Management Bv invested in 1.21M shares. Fil Limited, a Bermuda-based fund reported 652,043 shares. Nationwide Fund holds 0.02% or 146,860 shares in its portfolio. Peak6 Ltd Partnership holds 13,459 shares or 0% of its portfolio. 29,295 are owned by Gsa Partners Llp. Toth Fincl Advisory Corp accumulated 19,925 shares.
Since August 4, 2017, it had 0 insider purchases, and 9 selling transactions for $1.53 million activity. Another trade for 5,209 shares valued at $234,509 was made by Gibbons Mary Lourdes on Friday, October 20. The insider WEINSTOCK DAVID B sold 2,000 shares worth $77,820. 3,118 shares valued at $124,720 were sold by MCALEE LAWRENCE E JR on Friday, August 4.
Among 12 analysts covering Essent Group (NYSE:ESNT), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Essent Group has $60.0 highest and $22 lowest target. $43.71’s average target is -2.50% below currents $44.83 stock price. Essent Group had 39 analyst reports since August 12, 2015 according to SRatingsIntel. As per Monday, May 29, the company rating was maintained by Keefe Bruyette & Woods. The firm earned “Hold” rating on Monday, August 7 by Keefe Bruyette & Woods. As per Monday, August 7, the company rating was maintained by Barclays Capital. Barclays Capital maintained Essent Group Ltd. (NYSE:ESNT) on Friday, November 10 with “Overweight” rating. Susquehanna maintained Essent Group Ltd. (NYSE:ESNT) rating on Thursday, January 4. Susquehanna has “Buy” rating and $60.0 target. The stock has “Neutral” rating by Compass Point on Friday, August 5. Keefe Bruyette & Woods upgraded Essent Group Ltd. (NYSE:ESNT) on Wednesday, August 23 to “Buy” rating. Deutsche Bank downgraded the shares of ESNT in report on Friday, November 3 to “Hold” rating. The firm has “Neutral” rating by Credit Suisse given on Monday, May 2. BTIG Research maintained Essent Group Ltd. (NYSE:ESNT) rating on Thursday, November 9. BTIG Research has “Buy” rating and $49.0 target.
Analysts await Essent Group Ltd. (NYSE:ESNT) to report earnings on February, 9. They expect $0.78 EPS, up 14.71% or $0.10 from last year’s $0.68 per share. ESNT’s profit will be $76.78 million for 14.37 P/E if the $0.78 EPS becomes a reality. After $0.82 actual EPS reported by Essent Group Ltd. for the previous quarter, Wall Street now forecasts -4.88% negative EPS growth.
Analysts await Agile Therapeutics, Inc. (NASDAQ:AGRX) to report earnings on March, 14. They expect $-0.25 earnings per share, up 13.79% or $0.04 from last year’s $-0.29 per share. After $-0.22 actual earnings per share reported by Agile Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 13.64% negative EPS growth.